盖列-3和癌症免疫疗法:克服瘤免疫逃脱的糖生物学理由
Giorgia Scafetta1, Calogero D'Alessandria2, Armando Bartolazzi3,4
1Pathology Research Laboratory St, Andrea University Hospital, Via Di Grottarossa 1035, 00189, Rome, Italy.
Journal of experimental & clinical cancer research : CR
|February 5, 2024
概括
检查点抑制剂免疫疗法 (ICI) 已经改变了癌症治疗,但增强瘤反应需要更深入的理解. 加勒-3调制提供了一种有希望的策略,以克服瘤免疫逃逸并提高ICI的疗效.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 使用检查点抑制剂 (ICI) 的免疫疗法彻底改变了癌症治疗.
- 需要进一步改善瘤对ICI的反应,并建立在强大的生物基础上.
- 了解瘤细胞表型和瘤微环境 (TME) 相互作用对于提高ICI疗效至关重要.
研究的目的:
- 为了研究加勒-3在免疫瘤学中的作用.
- 为了探索 Galectin-3 作为克服瘤免疫逃逸的潜在目标.
- 为了提供一种机理性的理解,加勒-3对TME的免疫反应的影响.
主要方法:
- 详细分析瘤细胞表型.
- 在TME中分子相互作用的功能剖析.
- 评估免疫反应调节的体内研究.
主要成果:
- 加勒-3被确定为瘤生物学和免疫瘤学的关键分子.
- 盖莱克-3在体内表现出调节免疫反应的能力.
- 这些发现支持了加勒-3在瘤免疫逃生中的作用.
结论:
- 加勒-3 是瘤微环境中的一个重要因素.
- 向加勒-3是一种潜在的策略,可以增强癌症免疫疗法.
- 对加勒-3的机制的进一步研究可以指导新型免疫瘤治疗的开发.
相关概念视频
Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
Selectins
3.3K
Cell adhesion is an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
3.3K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367


